Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00746395 · ClinicalTrials.gov registry record · Phase 4
Randomized, Placebo-controlled Trial of Lubiprostone as a Preparation for Capsule Endoscopy
A Phase 4 study, sponsored by University of South Alabama.
- Completed
- Registry status
- Phase 4
- Development phase
- 45
- Enrollment target
NCT00746395: Completed Phase 4 study, sponsored by University of South Alabama.
NCT00746395 is a Phase 4 study that has completed, run by University of South Alabama. The registered enrollment target is 45 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00746395, a Phase 4 study, has completed, sponsored by University of South Alabama.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 45 participants
- Enrollment target
Study Summary
This investigation is designed to compare lubiprostone and placebo for cleansing and propulsion in preparation for capsule endoscopy.
Primary Outcome
Percent of subjects with capsule passage through small bowel
Interventions
- DRUG Placebo
- DRUG Lubiprostone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2008-04 |
| Est. Completion | 2008-09 |
| Phase | Phase 4 |
What the finished NCT00746395 record still lists
NCT00746395 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00746395 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00746395 about?
NCT00746395 is a clinical study titled "Randomized, Placebo-controlled Trial of Lubiprostone as a Preparation for Capsule Endoscopy". This investigation is designed to compare lubiprostone and placebo for cleansing and propulsion in preparation for capsule endoscopy.
What is the current status of trial NCT00746395?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 45 participants. The study started on 2008-04. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00746395?
The interventions under investigation include: Placebo (DRUG), Lubiprostone (DRUG).
Who is sponsoring clinical trial NCT00746395?
This trial is sponsored by University of South Alabama, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00746395's enrollment target sits among peer trials
45 1354th of 2000 higher than 638 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia